Debiopharm Investment S.A.

Mrs Calvayrac graduated at the University of Paris (Panthéon-Assas), where she obtained a "Diplôme d'Etudes Supérieures Spécialisées" in Business Law and Tax in 1988 (DESS, currently called "Master II Degree"). She then started a career in the banking sector, and she acquired a broad experience in various positions at Le Crédit Lyonnais (Crédit Agricole Group) in Marketing, Corporate Financing, Retail Banking and Human Resources, before becoming Director of the Financing Department for France, in charge of the Financing for Small Enterprises and of the Real Estate Financing for individuals. She joined Debiopharm Investment SA in April 2008 as General Secretary.

Mr. Favre obtained a Federal Diploma of Property Management in 2007 followed by an Advanced Federal Diploma of Real Estate Management in 2013. With 15 years' experience in real estate, he has held several management positions in life insurance and real estate management companies. Starting in 2010 he spent 6 years at Solvalor Fund Management SA where he subsequently worked as Property Manager, then Real Estate Manager, and subsequently Deputy Director. He joined Debiopharm Investment in 2017.

Mrs Le Coz Sanchez obtained in 1998 a master II degree from the University of Paris-La Sorbonne: DESS "Information and Decision Techniques in the Enterprise". She has completed her education by becoming a CFA® charterholder. Alexandra has previously worked in different leading multinational companies where she was responsible for Planning, Forecasting and Budgeting. She joined Debiopharm Investment in May 2010 as Financial Analyst. Since 2012, she has headed the Private Equity activities as part of investments diversification strategy. She serves on the Board of Directors of various companies in the portfolio and on some Funds' Advisory Committees.

Mr Moulin obtained a BA in International Relations in Geneva in 1991 (IUHEI), completed by a Postgrade Diploma in Economics from the London School of Economics and Political Science in 1993. He received the Federal Diploma for financial analyst and portfolio manager in 1998. He successively worked at Swiss Bank Corporation/UBS, Bank Morgan Stanley and Schroder & Co Banque SA, where he held several leading and strategic positions in investment strategy, asset allocation, portfolio management and financial analysis. He joined Debiopharm Investment in June 2014.